Systemair AB (0HDK)
London Exchange · UK · prices in SEK · close of 20 Oct 2026
Key indicators
| Last close | SEK 86.55 |
|---|---|
| 52-week range | 67.17 – 89.50 |
| Return, 1 month / 3 months | −2.8% / +10.0% |
| Return, 1 year / 3 years | +5.9% / +18.3% |
| Trend | Uptrend |
| RSI (14) | 52 |
| Volatility (1 year) | 28.6% |
| Worst drawdown (1 year) | -22.6% |
| Average daily value traded | 0.36M SEK |
| Dividend yield | 1.7% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Systemair AB is a Swedish manufacturer of ventilation and air conditioning equipment. The company makes fans, air handling units, air distribution products and related components for moving and conditioning air in buildings. Its customers include contractors, installers, consultants and building owners who need ventilation for homes, commercial premises and industrial facilities. Systemair is based in Skinnskatteberg, Sweden, and serves markets in many countries through its own sales companies and distributors.
On this site Systemair AB appears as a stock on the London Exchange (UK), code 0HDK, with prices in Swedish kronor (SEK). Our dividend records, which start in 2019, show payments in 7 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Systemair AB (0HDK) trades on the London Exchange in UK. It last closed at SEK 86.55 on 20 October 2026.
Its price-based Market X-Ray is 65 out of 100 (a fair price profile), ranking 936 of 3,787 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 5.9% and over the last three months it rose 10.0%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 75 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | 7.6% | ||
| From 52-week high | -3.3% | ||
| Momentum | 73 · Strong | Rising faster than most stocks on this exchange. | |
| 3-month return | 10.0% | ||
| 6-month return | 23.3% | ||
| 12-month return, skipping the last month | 8.9% | ||
| Stability (higher is calmer) | 66 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 28.6% | ||
| Worst drawdown, 1 year (smaller is calmer) | -22.6% | ||
| Liquidity | 43 · Weak | Thinly traded: prices can jump and exits can be hard. | |
| Average daily value traded | 0.36M SEK | ||
| Zero-volume days | 0.0% | ||
| Income | 48 · Weak | Dividend is small or irregular. | |
| Dividend yield | 1.7% | ||
| Years with dividends | 5 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Momentum: Rising faster than most stocks on this exchange.
Weak spots
- Liquidity: Thinly traded: prices can jump and exits can be hard.
- Income: Dividend is small or irregular.
Returns
| 1 week | −0.4% |
|---|---|
| 1 month | −2.8% |
| 3 months | +10.0% |
| 6 months | +23.3% |
| 1 year | +5.9% |
| 3 years | +18.3% |
| 5 years | – |
Signals
| 50-day / 200-day average | 85.22 / 80.42 |
|---|---|
| Golden / death cross (60 days) | Golden, 51 days ago |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 1.12 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 28 Aug 2026 | SEK 1.4500 |
| 29 Aug 2025 | SEK 1.3500 |
| 30 Aug 2024 | SEK 1.2000 |
| 1 Sep 2023 | SEK 1.1000 |
| 26 Aug 2022 | SEK 0.9000 |
| 27 Aug 2021 | SEK 3.0000 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.